Ahimsa Industries narrowed its net loss to ₹49.57 lakh for the financial year ended March 31, 2026, compared to a loss of ₹417.63 lakh in the previous year. The company's total income from operations fell sharply to ₹5.42 lakh from ₹959.87 lakh in FY25, reflecting the discontinuation of manufacturing operations during the year. The Board of Directors approved the audited financial results on May 30, 2026.

Financial Performance

The steep decline in revenue was accompanied by a reduction in total expenses, which stood at ₹54.98 lakh for FY26, down from ₹1,308.76 lakh in the prior year. The company reported a profit before tax of ₹(49.57) lakh. For the half-year ended March 31, 2026, the company recorded a net loss of ₹27.19 lakh on total income of ₹0.01 lakh.

Key Financial Metrics (₹ in Lakhs)

Operational and Strategic Updates

Management disclosed that the company has ceased its manufacturing operations and is actively evaluating new business opportunities in the pharmaceutical sector as part of its strategic realignment. The financial statements were prepared on a going concern basis, supported by management's confidence in discharging liabilities under the revised operational structure.

Audit and Compliance

Statutory Auditors M/s A N Shah & Associates issued an audit report with an unmodified opinion on the annual audited financial results. The auditors highlighted that no operations were carried out during the year, and balance sheet balances were carried forward from the previous year. Additionally, the company confirmed it is listed on the SME Exchange platform, making the Annual Secretarial Compliance Report inapplicable for the financial year.

The trading window for directors and key management personnel will open on June 02, 2026.

ahimsa industries appointed Ms. Arti Jain as a Non-Executive Independent Director for a term of five years effective May 27, 2026, following the resignation of Mr. Ashutosh Gandhi as Managing Director and Director. The board approved the appointment based on the recommendation of the Nomination and Remuneration Committee. Ms. Jain's appointment is subject to the approval of shareholders at the next General Meeting or within three months from the date of her appointment, whichever is earlier.

Mr. Ashutosh Gandhi resigned from his positions effective May 27, 2026, citing personal reasons. In his resignation letter, he stated that he is approaching the age of 60 years and plans to retire gradually from active professional responsibilities to devote more time to his personal life. Additionally, he intends to relocate outside India. Mr. Gandhi confirmed that there are no material reasons for his resignation other than those stated.

Ms. Arti Jain brings over eight years of experience in the Corporate Secretarial field, specializing in Corporate Law and conducting due diligence. She is a commerce graduate and provides advisory services for corporate matters. The company confirmed that she is not debarred from holding the office of Director by SEBI or any other authority and is not related to any director on the board.

The changes were disclosed to the National Stock Exchange of India Limited under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that all necessary regulatory compliances have been met regarding the resignation and appointment.

Key Board Changes